Maimon Yossi
Insider CIK 1385115 · PLX Vice President & CFO · AYLA CFO, Secretary and Treasurer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 31,950 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 19,170 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 9,460 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer deriv | 2023-01-19 | 2023-01-23 | 70,500 | — | $0 | 0 | SEC↗ |
| AYLA Old Ayala, Inc | D To issuer | 2023-01-19 | 2023-01-23 | 69,872 | — | $0 | 0 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award | 2022-05-16 | 2022-05-16 | 50,000 | — | $0 | 69,872 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2022-01-03 | 2022-01-05 | 31,950 | — | $0 | 31,950 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award deriv | 2021-01-04 | 2021-01-06 | 19,170 | — | $0 | 19,170 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award | 2021-01-04 | 2021-01-06 | 8,520 | — | $0 | 19,872 | SEC↗ |
| AYLA Ayala Pharmaceuticals, Inc | A Award | 2020-05-07 | 2020-05-11 | 11,352 | — | $0 | 11,352 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2018-09-13 | 2018-09-14 | 700,000 | — | $0 | 700,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | P Buy | 2015-12-14 | 2015-12-15 | 10,000 | $0.78 | $7.8K | 10,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2015-03-23 | 2015-05-07 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award | 2012-07-16 | 2012-07-18 | 185,000 | — | $0 | 185,000 | SEC↗ |
| PLX Protalix BioTherapeutics, | M Exercise deriv | 2012-05-02 | 2012-05-04 | 50,000 | — | $0 | 0 | SEC↗ |
| PLX Protalix BioTherapeutics, | M Exercise deriv | 2012-05-02 | 2012-05-04 | 75,964 | — | $0 | 0 | SEC↗ |
| PLX Protalix BioTherapeutics, | M Exercise | 2012-05-02 | 2012-05-04 | 75,964 | $0.97 | $73.7K | 75,964 | SEC↗ |
| PLX Protalix BioTherapeutics, | S Sale | 2012-05-02 | 2012-05-04 | 125,964 | $7.13 | $898.1K | 0 | SEC↗ |
| PLX Protalix BioTherapeutics, | M Exercise | 2012-05-02 | 2012-05-04 | 50,000 | $2.65 | $132.5K | 125,964 | SEC↗ |